| Name: FDA Approves Avastin(TM)a Targeted Therapy for First-Line Metastatic Colorectal Cancer Patients
Description: FDA Approves Avastin(TM)a Targeted Therapy for First-Line Metastatic Colorectal Cancer Patients. First Anti-Angiogenesis Treatment Approved for Treating Cancer SOUTH SAN FRANCISCOCalif.Feb. randomizedPhase III study of patients with metastatic colorectal cancer. In the pivotal trialthe most in the treatment of metastatic colorectal cancerwith the approval of an
Category: Metastatic Colorectal Cancer
Url: http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/02-26-2004/0002117720&EDATE
Date: Oct 7, 2005
Current Rating: 0.00
Clicks/Hits Received: 0 |
|